Ethylene Oxide – Flexible Chamber Technology is Andersen’s proprietary and award-winning sterilization process. It is shared by the Andersen Anprolene and EOGas 4 models.
Andersen Sterilizers founder, H.W. Andersen, M.D., designed and patented the first self-contained Biological Indicator (BI) in 1969. Long after his patent expired, his invention has become an industry in and of itself.
“EO sterilization has continued to advance since the ’60s and ’70s, and while there are still risks, updates to the delivery technology, EO’s materials compatibility, and penetration capabilities mean there are rewards to the modality that you should consider,” said Seth Hendee of Healthmark Industries, Inc. in his article Ethylene Oxide Risk vs Reward.
You should you care about Tax Code 179 because it allows you to deduct 100% of the cost of your new gas sterilizer from your gross income! Tax Code 179 is an incentive created by the US government to encourage businesses to buy equipment and invest in themselves. Put Tax Code 179 to work for you.
The useful life of all Andersen sterilizers is 10 years from the date of manufacture. Useful life refers to the time-period during which Andersen Sterilizers will maintain a spare parts inventory and provide service to repair the sterilizer.
All chemicals capable of achieving terminal sterility are inherently dangerous requiring exposure monitoring, training and engineered redundancies designed to offer the highest level of operator protection. Claiming your sterilant is “safe” and “non-toxic” does a serious disservice to users who may, then, not treat the sterilant with the respect it deserves. Our aim in this post is not to compare H2O2 and EO (both are potentially dangerous and must be used with care). Instead, we hope to demonstrate widespread instances of operator injury in hopes of encouraging fair comparison and careful use.
You’re not going to believe how simple Andersen Sterilizer installation is. In fact, it’s the easiest in the industry! As easy as 1, 2, 3. Vent, Connect, Plug-in: Ready!
Andersen Sterilizers is pleased to announce its president and CEO, A.E. “Ted” May, has been appointed to a three-year term as Co-Chair of the Association for the Advancement of Medical Instrumentation (AAMI) Hospital Ethylene Oxide (EO) Sterilizer Working Group. May’s term begins September 2021.
When COVID-19 took over our lives in 2020, many felt the immediate need to help, but weren’t quite sure how. Carl May, grandson of company founder Dr. Harold W. Andersen, didn’t hesitate. He pressed pause on plans to attend college in Fall 2020 & joined Andersen’s contract sterilization sister company, Andersen Scientific, as a sterile processing technician where he spent months sterilizing millions of COVID test swabs for manufacturers across the country.
Is ethylene oxide (EO or EtO) more toxic than hydrogen peroxide? What are the most prevalent myths about EO in the industry today? What does the future of EO look like? Andersen’s President and CEO, A.E. (Ted) May joined Beyond Clean’s Justin Poulin for an intensely honest conversation about gas sterilization. In typical Beyond Clean fashion, Poulin asked the tough questions regarding the history surrounding EO and its role in the future of hospital sterile processing departments, specifically around duodenoscope and endoscope reprocessing.
Andersen’s innovation, affordability and customer service is earning headlines! North Carolina Biotechnology Center wrote an article “Andersen Sterilizers: An NC Company with a Global Impact” published this morning.
The Food and Drug Administration (FDA) announced it is investigating reports of infections associated with reprocessed urological endoscopes. The FDA received more than 450 medical device reports (MDRs) describing post-procedure patient infections or other contamination issues associated with reprocessing urological endoscopes. Andersen’s EOGas 4 presents an FDA-cleared terminal sterilization option for the urological endoscopes under investigation, as well as significantly longer and smaller diameter scopes.
Andersen’s EOGas 4 is the first, and only, sterilization system FDA 510k cleared for terminal sterilization of duodenoscopes and colonoscopes. A true game changer for healthcare facilities that sterilize these critical instruments. On a recent Beyond Clean podcast, Ted May, Andersen President and CEO, and Dr. Larry Muscarella of LFM Healthcare Solutions LLC, take you inside the science behind this one-of-a-kind sterilization technology proven to sterilize the toughest endoscopes on the market.
Andersen’s manufacturing team recently welcomed a newly commissioned Humidichip assembly machine that will increase production of the consumable by 400%. After about 6 months to build and ship, it has now been crane lifted to its new home in Andersen’s manufacturing headquarters in Haw River, NC.
Andersen’s EOGas 4 has received FDA 510(k) clearance for the only terminal sterilization solution for duodenoscopes and colonoscopes. With this clearance, the EOGas 4 sterilization system reflects the FDA’s latest validation expectations for terminal sterilization of lumened devices, including those with elevator mechanisms.
